CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 55.6 USD -1.1%
Updated: May 20, 2024
CRSP
/
Income Statement
/
Income from Continuing Operations

CRISPR Therapeutics AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CRISPR Therapeutics AG
Income from Continuing Operations Peer Comparison

Comparables:
ADCT
ACIU
BSLN
IDIA
KURN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
CRISPR Therapeutics AG
NASDAQ:CRSP
Income from Continuing Operations
-$217.1m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Income from Continuing Operations
-$234.5m
CAGR 3-Years
2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Income from Continuing Operations
-CHf54.2m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Income from Continuing Operations
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Income from Continuing Operations
-CHf827.9m
CAGR 3-Years
-19%
CAGR 5-Years
-122%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Income from Continuing Operations
-CHf13.7m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is CRISPR Therapeutics AG's Income from Continuing Operations?
Income from Continuing Operations
-217.1m USD

Based on the financial report for Mar 31, 2024, CRISPR Therapeutics AG's Income from Continuing Operations amounts to -217.1m USD.

What is CRISPR Therapeutics AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-3%

Over the last year, the Income from Continuing Operations growth was 59%. The average annual Income from Continuing Operations growth rates for CRISPR Therapeutics AG have been 18% over the past three years , -3% over the past five years .

ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.